Raven 705CA

Hazard statements (CLP)

H315, H318, H335, H336, H350, H373

Code

Statements

H315

Causes skin irritation

Signal word

Danger

Classifications

Skin corrosive 2 Reversible adverse effects in dermal tissue, Draize score: >= 2.3 < 4.0 or persistent inflammation. Eye corrosive 1 Serious eye damage: Irreversible damage 21 days after exposure, Draize score: Corneal opacity >= 3, Iritis > 1.5 Carcinogen 1A Known Human Carcinogen Based on human evidence. Organ toxin single 3 Transient target organ effects- Narcotic effects- Respiratory exposure tract irritation. Organ toxin repeated 2 Presumed to be harmful to human health- Animal studies with exposure significant toxic effects relevant to humans at generally moderate exposure (guidance)- Human evidence in exceptional cases.

Hazard statements

H315 Causes skin irritation. H318 Causes serious eye damage. H335 May cause respiratory irritation. H336 May cause drowsiness or dizziness. H350 May cause cancer. H373 May cause damage to organs through prolonged or repeated exposure.

Precautionary statements

P201 Obtain special instructions before use. P202 Do not handle until all safety precautions have been read and understood. P260 Do not breathe dust/fume/gas/mist/vapours/spray. P261 Avoid breathing dust/fume/gas/mist/vapours/spray. P264 Wash thoroughly after handling. P271 Use only outdoors or in a well-ventilated area. P280 Wear protective gloves/protective clothing/eye protection/face protection. P281 Use personal protective equipment as required. P310 Immediately call a POISON CENTER or doctor/physician. P312 Call a POISON CENTER or doctor/physician if you feel unwell. P314 Get Medical advice/attention if you feel unwell. P321 Specific treatment (see Section 4 of the SDS). P362 Take off contaminated clothing and wash before reuse. P302+P352 IF ON SKIN: Wash with soap and water. P304+P340 IF INHALED: Remove person to fresh air and keep at rest in a position comfortable for breathing. P305+P351+P338 IF IN EYES: Rinse continuously with water for several minutes. Remove contact lenses if present and easy to do - continue rinsing. P308+P313 IF exposed or concerned: Get medical advice/attention. P332+P313 If skin irritation occurs: Get medical advice/attention. P405 Store locked up. P403+P233 Store in a well ventilated place. Keep container tightly closed. P501 Dispose of contents/container according to Section 13 of the SDS. Acute Toxicity: Acute silicosis can occur with exposures to very high concentrations of respirable crystalline silica over a very short time period, sometimes as short as a few months. The symptoms of acute silicosis include progressive shortness of breath, fever, cough and weight loss. Acute silicosis is fatal.

Medical Conditions Generally Aggravated by Exposure

The condition of individuals with lung disease (e.g. bronchitis, emphysema, chronic obstructive pulmonary disease, etc...) can be aggravated by exposure.

Potential chronic health

Silicosis: Chronic or Ordinary Silicosis is the most common form of silicosis, and can occur after many years of inhalation of low levels of airborne respirable crystalline silica dust. Silicosis is a progressive, disabling and sometimes fatal lung disease. It is characterized by lung lesions (shown as radiographic opacities) less than 1 centimeter in diameter, primarily in the upper lung zones. Often, simple silicosis is not associated with symptoms, detectable changes in lung function or disability. Simple silicosis may be progressive and may develop into complicated silicosis or progressive massive fibrosis (PMF). Complicated silicosis or PMF is characterized by lung lesions greater than 1 centimeter in diameter. There may be no symptoms associated with complicated silicosis or PMF, but if present they are shortness of breath, wheezing, cough and sputum productions. Complicated silicosis or PMF may be associated with decreased lung function and may be disabling. Advanced complicated silicosis or PMF can result in heart disease secondary to the lung disease and may lead to death. Accelerated silicosis can occur with exposure to high concentrations of respirable crystalline silica over a relative short period; the lung lesions can appear within 5 years of initial exposure. Accelerated silicosis is similar to chronic silicosis, except that lung lesions appear earlier and progression is more rapid.